AJRCCMAmerican Lung Association, 2008 - Critical care medicine |
Contents
EDITORIALS | 437 |
GE A Christopher Boyd J Alastair Innes David J Porteous and Andrew P Greening | 444 |
GI www atsjournals org | 453 |
Copyright | |
3 other sections not shown
Other editions - View all
Common terms and phrases
activity acute adverse events airflow obstruction airway alveolar ALVESCO analysis angiogenesis apoptosis arginase asbestos assay associated asthma bacterial pneumonia baseline bosentan budesonide calgranulin cells Center chronic obstructive pulmonary Clin clinical trials cohort commercial entity compared control subjects COPD Critical Care Medicine cytokine decreased effects emphysema exposure expression factor FEV1 fibrocytes fibrosis Figure financial relationship formoterol gene Health iloprost immune Immunol increased induced infection inflammation inflammatory influenza inhaled corticosteroids LETAIRIS levels lung cancer lung injury manuscript mBODE measured Medical mesothelioma mice mortality mutations neutrophils nonsevere NRF2 obesity obstructive pulmonary disease online supplement oral pathways patients with asthma PBEF pediatric PH.D phenotype placebo potential protein pulmonary arterial hypertension pulmonary fibrosis pulmonary hypertension rats receptor Respir Crit respiratory response rhPBEF risk samples sepsis severe asthma significant smoking SNPs sputum SYMBICORT symptoms telomerase telomere therapy Thoracic treatment vaccination vascular Ventavis wheezing ZYVOX